SCHEMBL12619518

SCHEMBL12619518

CCOC(=O)N1CCN(C(=O)CN2CC(C)(C)OC[C@H]2C(=O)Nc2cc(Cl)cc3c2[nH]c2cnccc23)CC1

nearest known ligand 0.57

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ ICOSLG O75144 10/20 0.57
▸ ICOS Q9Y6W8 10/20 0.57
▸ CHUK O15111 14/20 0.48
▸ MEN1 O00255 1/20 0.42
▸ IKBKB O14920 1/20 0.42
▸ PIM1 P11309 1/20 0.42
▸ KMT2A Q03164 1/20 0.42
▸ PIM3 Q86V86 1/20 0.42
▸ IKBKG Q9Y6K9 1/20 0.42
▸ KDM4E B2RXH2 1/20 0.35
▸ USP2 O75604 1/20 0.35
▸ ALDH1A1 P00352 1/20 0.35
▸ LMNA P02545 1/20 0.35
▸ MAPT P10636 1/20 0.35
▸ HPGD P15428 1/20 0.35
▸ MAPK1 P28482 1/20 0.35
▸ SMN1; SMN2 Q16637 1/20 0.35
▸ NPSR1 Q6W5P4 1/20 0.35
▸ HSD17B10 Q99714 1/20 0.35
▸ NOS1 P29475 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL12619785 0.92 ICOSLG (0.60) ICOSLGICOSCHUKMEN1IKBKB
SCHEMBL12619510 0.92 ICOSLG (0.54) ICOSLGICOSCHUKMEN1IKBKB
SCHEMBL12619807 0.92 ICOSLG (0.58) ICOSLGICOSCHUKMEN1IKBKB
SCHEMBL12619442 0.92 ICOSLG (0.59) ICOSLGICOSCHUKMEN1IKBKB
SCHEMBL1801476 0.92 ICOSLG (0.59) ICOSLGICOSCHUKMEN1IKBKB
SCHEMBL1798960 0.92 ICOSLG (0.61) ICOSLGICOSCHUKMEN1IKBKB
SCHEMBL1800310 0.91 ICOSLG (0.60) ICOSLGICOSCHUKMEN1IKBKB
SCHEMBL12619486 0.90 ICOSLG (0.59) ICOSLGICOSCHUKMEN1IKBKB
SCHEMBL12619612 0.90 ICOSLG (0.59) ICOSLGICOSCHUKMEN1IKBKB
SCHEMBL12619712 0.90 ICOSLG (0.59) ICOSLGICOSCHUKMEN1IKBKB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7951801-B2 For therapy of inflammatory disease and cancer MILLENNIUM PHARMACEUTICALS, INC. (US) 2011-05-31 — — US disclosed
US-7951801-B2 For therapy of inflammatory disease and cancer MILLENNIUM PHARMACEUTICALS, INC. (US) 2011-05-31 — — US disclosed
EP-2206713-A1 Beta-carbolines useful for treating inflammatory disease Millennium Pharmaceuticals, Inc. (US) 2010-07-14 — — EP disclosed
Send feedback